Definitions for Astrazeneca
as·trazeneca

WikipediaRate this definition:2.8 / 5 votes

1. AstraZeneca

   AstraZeneca plc is a British-Swedish multinational pharmaceutical and biopharmaceutical company. In 2013, it moved its headquarters to Cambridge, UK, and concentrated its R&D in three sites: Cambridge; Gaithersburg, Maryland, USA (location of MedImmune) for work on biopharmaceuticals; and Mölndal (near Gothenburg) in Sweden, for research on traditional chemical drugs. AstraZeneca has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.The company was founded in 1999 through the merger of the Swedish Astra AB and the English Zeneca Group (itself formed by the demerger of the pharmaceutical operations of Imperial Chemical Industries in 1993). Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). AstraZeneca has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. It has secondary listings on the New York Stock Exchange and the OMX exchange.

How to pronounce Astrazeneca?

1. Alex

   US English

   David

   US English

   Mark

   US English

   Daniel

   British

   Libby

   British

   Mia

   British

   Karen

   Australian

   Hayley

   Australian

   Natasha

   Australian

   Veena

   Indian

   Priya

   Indian

   Neerja

   Indian

   Zira

   US English

   Oliver

   British

   Wendy

   British

   Fred

   US English

   Tessa

   South African

How to say Astrazeneca in sign language?

Numerology

1. Chaldean Numerology

   The numerical value of Astrazeneca in Chaldean Numerology is: 1

2. Pythagorean Numerology

   The numerical value of Astrazeneca in Pythagorean Numerology is: 5

Examples of Astrazeneca in a Sentence

1. Jens Spahn:

   If the approvals we expect come through for vaccines developed by AstraZeneca, CureVac or Johnson Johnson, then in the summer Germany will be able to offer everyone a vaccine, we need patience. We have started the road out of this but a long path lies ahead.

2. Professor Barry Schoub:

   AstraZeneca may well have a place, it may well have a significant place. This is only a suspension, not turfing it out, we have got in South Africa a problem with the variant, it all hinges on that.

3. Ruud Dobber:

   We need to have that discussion with our senior executive team, and then with the board of AstraZeneca. We are exploring different options, but it is far too early at this stage to conclude that (process), hopefully before the year ends, we will have a better view how to move forward in the next few years.

4. Takashi Akahane:

   The upfront payment is particularly large. It's a sign that AstraZeneca assumes the drug will become mainstream in the next generation.

5. An NHS spokeswoman:

   As the CMO has said, the main barrier to vaccine delivery will be availability of the vaccine, and it is completely untrue that staffing constraints are currently standing in the way of vaccine rollout, with the NHS ready to deliver vaccine as supply becomes available, the NHS is off to a strong start vaccinating one million people and now beginning the rapid rollout of the Oxford-AstraZeneca, which will enable us to vaccinate millions more people with the support of tens of thousands of vaccinators.

Popularity rank by frequency of use

References

1. ^ Wikipedia
   https://en.wikipedia.org/wiki/Astrazeneca